CIK 0001768224 · Accelerated filer<br>Smaller reporting company
Arcturus Therapeutics Holdings Inc.
Sign in to watch- Ticker
- ARCT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 8589002660
- Business address
- 10285 SCIENCE CENTER DRIVE, SAN DIEGO, CA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-11-01 | Chivukula Pad Chief Scientific Officer & COO | Sale | −10,000 | $44.41 | $444K | 612,548 |
| 2021-10-01 | Chivukula Pad Chief Scientific Officer & COO | Sale | −10,000 | $44.36 | $444K | 622,548 |
| 2021-09-01 | Chivukula Pad Chief Scientific Officer & COO | Sale | −10,000 | $55.86 | $559K | 632,548 |
| 2021-08-11 | Ultragenyx Pharmaceutical Inc. Director | Sale | −75,000 | $45.83 | $3.4M | 1,400,000 |
| 2021-08-10 | Ultragenyx Pharmaceutical Inc. Director | Sale | −725,000 | $55.44 | $40.2M | 1,475,000 |
| 2021-08-03 | Chivukula Pad Chief Scientific Officer & COO | Sale | −10,000 | $40.07 | $401K | 642,548 |
| 2021-06-18 | Parschauer Karah Herdman Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2021-06-18 | Marquet Magda Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2021-06-18 | HOLMES EDWARD W Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2021-06-18 | BARLOW JAMES F Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2021-06-18 | FARRELL PETER C Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2021-04-01 | Chivukula Pad Chief Scientific Officer & COO | Sale | −10,000 | $42.95 | $430K | 652,548 |
| 2021-03-01 | Chivukula Pad Chief Scientific Officer & COO | Sale | −10,000 | $54.23 | $542K | 662,548 |
| 2021-02-01 | Chivukula Pad Chief Scientific Officer & COO | Sale | −10,000 | $75.31 | $753K | 672,548 |
| 2021-01-04 | Chivukula Pad Chief Scientific Officer & COO | Sale | −10,000 | $46.40 | $464K | 682,548 |
| 2020-12-18 | Kummerfeld Keith C See Remarks | Grant or award · Stock Option (right to buy) | +45,000 | 45,000 | ||
| 2020-12-18 | Chivukula Pad Chief Scientific Officer & COO | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2020-12-18 | Payne Joseph E President and CEO | Grant or award · Stock Option (right to buy) | +175,000 | 175,000 | ||
| 2020-12-18 | SASSINE ANDY Chief Financial Officer | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2020-12-18 | Hughes Steven George Chief Development Officer | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 |
Page 7 of 9 · 178 trades